ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma

Male Clinicopathology of Fibrous Tumors and Treatment Strategies DNA Mutational Analysis Adenoid Cystic -- genetics -- pathology mutation ; spiradenoma ; spiradenocarcinoma Gene Whole Exome Sequencing DNA Methyltransferase 3A Cohort Studies Somatic cell Loss of Function Mutation Cylindromatosis Gene Germline mutation 80 and over Pathology Missense mutation Adenoid Cystic DNA (Cytosine-5-)-Methyltransferases Aged, 80 and over 0303 health sciences Q Life Sciences Middle Aged Carcinoma, Adenoid Cystic Deubiquitinating Enzyme CYLD 3. Good health Technologie de l'environnement, contrôle de la pollution Malignant transformation Hedgehog Signaling in Development and Cancer Medicine Female Protein Kinases -- genetics Adult 572 Germline Tumor Suppressor Protein p53 -- genetics Science Cylindroma Mutation, Missense 610 Dermatology Cancer research Article Protein Domains -- genetics 03 medical and health sciences Protein Domains Rheumatology Deubiquitinating Enzyme CYLD -- genetics Biochemistry, Genetics and Molecular Biology Health Sciences Adnexal Neoplasms Genetics Chimie Humans Cutaneous Adnexal Neoplasms and Related Syndromes Sweat Glands -- pathology Molecular Biology Biology Aged Carcinoma, Adenoid Cystic -- genetics -- pathology Physique DNA (Cytosine-5-)-Methyltransferases -- genetics Carcinoma Astronomie Sweat Gland Neoplasms -- genetics -- pathology Sweat Glands Sweat Gland Neoplasms FOS: Biological sciences Mutation contrôle de la pollution Technologie de l'environnement Missense Tumor Suppressor Protein p53 Protein Kinases
DOI: 10.1038/s41467-019-09979-0 Publication Date: 2019-05-17T10:04:09Z
ABSTRACT
AbstractSpiradenoma and cylindroma are distinctive skin adnexal tumors with sweat gland differentiation and potential for malignant transformation and aggressive behaviour. We present the genomic analysis of 75 samples from 57 representative patients including 15 cylindromas, 17 spiradenomas, 2 cylindroma–spiradenoma hybrid tumors, and 24 low- and high-grade spiradenocarcinoma cases, together with morphologically benign precursor regions of these cancers. We reveal somatic or germline alterations of the CYLD gene in 15/15 cylindromas and 5/17 spiradenomas, yet only 2/24 spiradenocarcinomas. Notably, we find a recurrent missense mutation in the kinase domain of the ALPK1 gene in spiradenomas and spiradenocarcinomas, which is mutually exclusive from mutation of CYLD and can activate the NF-κB pathway in reporter assays. In addition, we show that high-grade spiradenocarcinomas carry loss-of-function TP53 mutations, while cylindromas may have disruptive mutations in DNMT3A. Thus, we reveal the genomic landscape of adnexal tumors and therapeutic targets.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....